Literature DB >> 12668083

High-performance liquid chromatographic method with diode array detection to identify and quantify atypical antipsychotics and haloperidol in plasma after overdose.

K Titier1, S Bouchet, F Péhourcq, N Moore, M Molimard.   

Abstract

For toxicological purposes, an HPLC assay was developed for the simultaneous determination of haloperidol and atypical antipsychotics (risperidone, 9-hydroxyrisperidone, olanzapine, clozapine) in human plasma. After a double-step liquid-liquid extraction, compounds were separated on a C(8) column eluted with a gradient of acetonitrile and phosphate buffer 50 mM pH 3.8. A sequential ultraviolet detection was used (260, 280 and 240 nm). Calibration curves were linear in the range 10-1000 ng/ml. The limits of quantification were 5 ng/ml for all drugs. Average accuracy at four concentrations ranged from 93 to 109%. Both inter- and intra-day variation coefficients were lower than 11% for all drugs. This simple and rapid method (run time<15 min) is currently used for poison management.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12668083     DOI: 10.1016/s1570-0232(02)01003-6

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  9 in total

1.  Simultaneous determination of five antipsychotic drugs in rat plasma by high performance liquid chromatography with ultraviolet detection.

Authors:  Guodong Zhang; Alvin V Terry; Michael G Bartlett
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2007-05-26       Impact factor: 3.205

Review 2.  Does olanzapine warrant clinical pharmacokinetic monitoring in schizophrenia?

Authors:  Erin Schwenger; Jane Dumontet; Mary H H Ensom
Journal:  Clin Pharmacokinet       Date:  2011-07       Impact factor: 6.447

3.  Simultaneous RP-HPLC-DAD quantification of bromocriptine, haloperidol and its diazepane structural analog in rat plasma with droperidol as internal standard for application to drug-interaction pharmacokinetics.

Authors:  Johnique Billups; Cynthia Jones; Tanise L Jackson; Seth Y Ablordeppey; Shawn D Spencer
Journal:  Biomed Chromatogr       Date:  2010-07       Impact factor: 1.902

4.  Development and Validation of Liquid Chromatography/Tandem Mass Spectrometry Analysis for Therapeutic Drug Monitoring of Risperidone and 9-Hydroxyrisperidone in Pediatric Patients with Autism Spectrum Disorders.

Authors:  Natchaya Vanwong; Santirat Prommas; Apichaya Puangpetch; Yaowaluck Hongkaew; Nopadol Nuntamool; Chalitpol Na Nakorn; Nattawat Ngamsamut; Penkhae Limsila; Chonlaphat Sukasem
Journal:  J Clin Lab Anal       Date:  2016-06-26       Impact factor: 2.352

5.  Atypical antipsychotic drugs induce derangements in glucose homeostasis by acutely increasing glucagon secretion and hepatic glucose output in the rat.

Authors:  G C Smith; C Chaussade; M Vickers; J Jensen; P R Shepherd
Journal:  Diabetologia       Date:  2008-10-09       Impact factor: 10.122

6.  New Modified UPLC/Tandem Mass Spectrometry Method for Determination of Risperidone and Its Active Metabolite 9-Hydroxyrisperidone in Plasma: Application to Dose-Dependent Pharmacokinetic Study in Sprague-Dawley Rats.

Authors:  Essam Ezzeldin; Marwa Tammam; Nisreen F Abo Talib
Journal:  Int J Anal Chem       Date:  2017-05-03       Impact factor: 1.885

7.  UPLC-Tandem Mass Spectrometry Method for Simultaneous Determination of Fluoxetine, Risperidone, and Its Active Metabolite 9-Hydroxyrisperidone in Plasma: Application to Pharmacokinetics Study in Rats.

Authors:  Essam Ezzeldin; Nisreen F Abo-Talib; Marwa H Tammam
Journal:  J Anal Methods Chem       Date:  2017-06-01       Impact factor: 2.193

8.  RP-HPLC Estimation of Risperidone in Tablet Dosage Forms.

Authors:  S L Baldania; K K Bhatt; R S Mehta; D A Shah
Journal:  Indian J Pharm Sci       Date:  2008 Jul-Aug       Impact factor: 0.975

9.  Clozapine Use During Pregnancy and Lactation: A Case-Series Report.

Authors:  M Luisa Imaz; Giovanni Oriolo; Mercè Torra; Dolors Soy; Lluïsa García-Esteve; Rocio Martin-Santos
Journal:  Front Pharmacol       Date:  2018-03-27       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.